{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T11:05:39Z","timestamp":1743937539483},"reference-count":25,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":137,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.vaccine.2013.01.002","type":"journal-article","created":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T17:45:42Z","timestamp":1357839942000},"page":"1759-1764","source":"Crossref","is-referenced-by-count":10,"title":["Meta-analysis of pregnancy outcomes in pooled randomized trials on a prophylactic adjuvanted glycoprotein D subunit herpes simplex virus vaccine"],"prefix":"10.1016","volume":"31","author":[{"given":"Fernanda","family":"Tavares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Cheuvart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Heineman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Arellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Dubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.01.002_bib0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/14712598.8.2.235","article-title":"Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients","volume":"8","author":"Beran","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0010","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1086\/429240","article-title":"Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine","volume":"40","author":"Bernstein","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0015","series-title":"Proc-StatXact 4 for SAS Users, User Manual","author":"Cytel Software Corporation","year":"1999"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4161\/hv.5.5.7211","article-title":"Safety of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials","volume":"5","author":"Descamps","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0025","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0030","series-title":"Guideline on the Exposure to Medicinal Products during Pregnancy: Need for Post-authorisation Data","author":"European Medicines Agency (Committee for Medicinal Products for Human Use)","year":"2005"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2105\/AJPH.78.1.40","article-title":"Correcting spontaneous abortion rates for the presence of induced abortion","volume":"78","author":"Figa\u2019-Talamanca","year":"1988","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0040","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1016\/j.vaccine.2011.04.046","article-title":"The safety evaluation of adjuvants during vaccine development: the AS04 experience","volume":"29","author":"Garcon","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00001648-199101000-00006","article-title":"The fetal life table revisited: spontaneous abortion rates in three Kaiser Permanente cohorts","volume":"2","author":"Goldhaber","year":"1991","journal-title":"Epidemiology"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/aje\/152.3.287","article-title":"Re: Estimates of the annual number of clinically recognized pregnancies in the United States, 1981\u20131991","volume":"152","author":"Goldhaber","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0055","first-page":"269","article-title":"Estimating the probability of spontaneous abortion in the presence of induced abortion and vice versa","volume":"107","author":"Hammerslough","year":"1992","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0060","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1016\/j.vaccine.2008.07.002","article-title":"Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica","volume":"26","author":"Herrero","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0065","first-page":"1","article-title":"General recommendations on immunization: recommendations of the advisory committee on immunization practices (ACIP)","volume":"60","author":"National Center for Immunization and Respiratory Diseases","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0070","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1136\/bmj.320.7251.1708","article-title":"Maternal age and fetal loss: population based register linkage study","volume":"320","author":"Nybo Andersen","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0075","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0080","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/oxfordjournals.aje.a009747","article-title":"Estimates of the annual number of clinically recognized pregnancies in the United States, 1981\u20131991","volume":"149","author":"Saraiya","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0085","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/oxfordjournals.aje.a113542","article-title":"Spontaneous abortion and induced abortion: an adjustment for the presence of induced abortion when estimating the rate of spontaneous abortion from cross-sectional studies","volume":"117","author":"Susser","year":"1983","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0090","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1016\/j.vaccine.2011.04.114","article-title":"Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study","volume":"29","author":"Tavares","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0095","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.1016\/j.vaccine.2008.09.049","article-title":"Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines","volume":"26","author":"Verstraeten","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0100","doi-asserted-by":"crossref","first-page":"c712","DOI":"10.1136\/bmj.c712","article-title":"Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials","volume":"340","author":"Wacholder","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ajim.4700040121","article-title":"Surveillance of pregnancy loss in human populations","volume":"4","author":"Wilcox","year":"1983","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0110","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/oxfordjournals.aje.a113220","article-title":"Spontaneous abortion over time: comparing occurrence in two cohorts of women a generation apart","volume":"114","author":"Wilcox","year":"1981","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198807283190401","article-title":"Incidence of early loss of pregnancy","volume":"319","author":"Wilcox","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0015-0282(16)58144-8","article-title":"Estimates of human fertility and pregnancy loss","volume":"65","author":"Zinaman","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.vaccine.2013.01.002_bib0125","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1001\/jama.2010.1729","article-title":"Transplacental antibody transfer following maternal immunization with a pandemic 2009 influenza A (H1N1) MF59-adjuvanted vaccine","volume":"304","author":"Zuccotti","year":"2010","journal-title":"JAMA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13000030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13000030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T15:50:36Z","timestamp":1539964236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13000030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":25,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0264410X13000030"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.01.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}